22.9 C
New York
Thursday, August 27, 2026

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

148,415FansLike
396,312FollowersFollow
2,710SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x